Automated identification of incidental hepatic steatosis on Emergency Department imaging using large language models
- PMID: 39969431
- PMCID: PMC11841845
- DOI: 10.1097/HC9.0000000000000638
Automated identification of incidental hepatic steatosis on Emergency Department imaging using large language models
Abstract
Background: Hepatic steatosis is a precursor to more severe liver disease, increasing morbidity and mortality risks. In the Emergency Department, routine abdominal imaging often reveals incidental hepatic steatosis that goes undiagnosed due to the acute nature of encounters. Imaging reports in the electronic health record contain valuable information not easily accessible as discrete data elements. We hypothesized that large language models could reliably detect hepatic steatosis from reports without extensive natural language processing training.
Methods: We identified 200 adults who had CT abdominal imaging in the Emergency Department between August 1, 2016, and December 31, 2023. Using text from imaging reports and structured prompts, 3 Azure OpenAI models (ChatGPT 3.5, 4, 4o) identified patients with hepatic steatosis. We evaluated model performance regarding accuracy, inter-rater reliability, sensitivity, and specificity compared to physician reviews.
Results: The accuracy for the models was 96.2% for v3.5, 98.3% for v4, and 98.8% for v4o. Inter-rater reliability ranged from 0.99 to 1.00 across 10 iterations. Mean model confidence scores were 2.9 (SD 0.8) for v3.5, 3.9 (SD 0.3) for v4, and 4.0 (SD 0.07) for v4o. Incorrect evaluations were 76 (3.8%) for v3.5, 34 (1.7%) for v4, and 25 (1.3%) for v4o. All models showed sensitivity and specificity above 0.9.
Conclusions: Large language models can assist in identifying incidental conditions from imaging reports that otherwise may be missed opportunities for early disease intervention. Large language models are a democratization of natural language processing by allowing for a user-friendly, expansive analyses of electronic medical records without requiring the development of complex natural language processing models.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.
Conflict of interest statement
Mark Dredze consults for Bloomberg LP and Good Analytics. Jeremiah S. Hinson is employed by Beckman Coulter. The remaining authors have no conflicts to report.
Figures
References
-
- Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111S:154170. - PubMed
-
- Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin M. Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020. Clin Gastroenterol Hepatol. 2024;22:1330–1332.e4. - PubMed
-
- Stern C, Castera L. Non-invasive diagnosis of hepatic steatosis. Hepatol Int. 2017;11:70–78. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
